ZW

Zehong Wan

GL Glaxo Group Limited: 22 patents #21 of 1,368Top 2%
SL Smithkline Beecham Limited: 3 patents #419 of 1,624Top 30%
📍 Shanghai, PA: #9 of 66 inventorsTop 15%
Overall (All Time): #97,397 of 4,157,543Top 3%
35
Patents All Time

Issued Patents All Time

Showing 1–25 of 35 patents

Patent #TitleCo-InventorsDate
11999746 Compounds Xiaomin Zhang, Jian Wang, Matthew Robert Sender, Eric Steven Manas, Raphael Anthony Rivero +3 more 2024-06-04
10975081 Substituted fused pyrazole compounds and their use as LRRK2 inhibitors Xiao Ding, Yun Jin, Qian Liu, Feng Ren, Yingxia Sang +5 more 2021-04-13
10618901 LRRK2 inhibitors for the treatment of Parkinson's disease Xiao Ding, Qian Liu, Yingxia Sang, Luigi Piero Stasi, Baowei Zhao +1 more 2020-04-14
10428078 Compounds Xiaomin Zhang, Jian Wang, Matthew Robert Sender, Eric Steven Manas, Raphael Anthony Rivero +3 more 2019-10-01
10125141 Compounds Xiaomin Zhang, Jian Wang, Matthew Robert Sender, Eric Steven Manas, Raphael Anthony Rivero +3 more 2018-11-13
10087186 Compounds as LRRK2 kinase inhibitors Xiao Ding, Luigi Piero Stasi, Colin Michael Edge 2018-10-02
9815841 Compounds Xiao Ding, Qian Liu, Kai Long, Yingxia Sang, Luigi Piero Stasi +2 more 2017-11-14
9783546 Compounds Xiaomin Zhang, Jian Wang 2017-10-10
9708330 2,3-dihydroimidazol[1,2-C]pyrimidin-5(1-H)-one based ipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitors Yingxia Sang, Qing Zhang 2017-07-18
9296755 3,4-dihydro-1H-pyrimido[1,6-a]pyrimidin-6(2H)-one compounds and their therapeutic applications Xiaomin Zhang 2016-03-29
9273054 Substituted pyrimido[1,6-a]pyrimidines as Lp-PLA2 inhibitors Kai Long, Xiaomin Zhang, Haihua Yu 2016-03-01
9174968 Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by LP-PLA2 Yun Jin, Qing Zhang 2015-11-03
9051325 Bicyclic [5,6] imidazo pyrimodone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA2 Yingxia Sang, Qing Zhang 2015-06-09
8975400 2,3-dihydroimidazo[1, 2-c] pyrimidin-5(1 H)-one compounds use as LP-PLA2 inhibitors Kai Long, Yingxia Sang, Xiaobo Su 2015-03-10
8871928 Tricyclic compounds, preparation methods, and their uses Xiaomin Zhang, Zhaolong Tong, Kai Long, Sarah E. Dowdell, Eric Steven Manas +1 more 2014-10-28
8859573 Pyrimidinone and pyridinone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA2 Xiaomin Zhang, Jian Wang, Cheng PENG, Yun Jin, Yimin Hu 2014-10-14
8637536 Pyrimidinone compounds for use in the treatment of diseases or conditions mediated by Lp-PLA2 Yun Jin, Qing Zhang 2014-01-28
8354416 7,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinase James Francis Callahan, Jeffrey C. Boehm, Anthony William James Cooper, Stefano Livia, Paul Bamborough +3 more 2013-01-15
8207176 Compounds James Francis Callahan, Jeffrey C. Boehm, Anthony William James Cooper, Stefano Livia, Paul Bamborough +3 more 2012-06-26
8084449 Dual pharmacophores—PDE4-muscarinic antagonistics James Francis Callahan, Guoliang Lin, Hongxing Yan 2011-12-27
8071588 Dual pharmacophores—PDE4-muscarinic antagonistics James Francis Callahan, Guoliang Lin, Hongxing Yan 2011-12-06
8067408 Dual pharmacophores—PDE4-muscarinic antagonistics James Francis Callahan, Guoliang Lin, Hongxing Yan 2011-11-29
7906531 M3 muscarinic acetylcholine receptor antagonists Hongxing Yan, Michael R. Palovich, Dramane I. Laine 2011-03-15
7678801 Compounds James Francis Callahan, Jeffrey C. Boehm, Anthony William James Cooper, Stefano Livia, Neysa Nevins +3 more 2010-03-16
7674789 Compounds James Francis Callahan, Hongxing Yan, Xichen Lin 2010-03-09